According to a report in the Taipei Times on January 13th, Kuomintang legislator Wan Meiling from Taiwan, China stated that since the revision of the law in 2023, the enforcement of the ban on e-cigarettes has been insufficient, with a very low proportion of cases resulting in fines.
The Legislative Yuan passed an amendment to the "Tobacco Hazard Prevention Act" in March 2023, which prohibits the sale, display, and use of e-cigarettes. However, according to data from the National Health Administration of the Ministry of Health and Welfare, out of 500,000 cases involving e-cigarettes since the amendment, only 1,247 fines have been issued, accounting for just 0.25%. Among these cases, 251 fines were for the sale of e-cigarettes, 619 were for the sale of heated tobacco products, and 404 were for illegal use.
Wan Meiling stated that from July to September 2024, police nationwide seized a total of 681 "zombie e-cigarettes" containing etizolam, averaging 227 devices per month.
Van Meiling emphasized the need to strengthen inspections and public awareness to prevent e-cigarettes and related drugs from impacting society. The Executive Yuan responded by stating that the Supreme Prosecutors' Office had held meetings on November 13 and 21, 2024 with the Ministry of Health and Welfare, Ministry of Finance, Ministry of the Interior, and the Ministry of Digital Development to discuss measures for preventing and controlling e-cigarettes.
In response to cases involving e-cigarettes containing illegal drugs, anti-drug agencies have been requested to strengthen investigations, trace the sources of the drugs, and uncover downstream drug use. The National Health Administration has held multiple meetings with online retailers and social media platforms to enhance investigations into the sale of e-cigarette products. They have also collaborated with the Ministry of Digital Development to block illegal websites, and worked with the Financial Supervision Committee to identify sellers' personal information and financial transactions.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
